APA

Dadu R., Waguespack S. G., Sherman S. I., Hu M. I., Busaidy N. L., Jimenez C., Habra M. A., Ying A. K., Bassett R. L. & Cabanillas M. E. (20150112). Efficacy and tolerability of different starting doses of sorafenib in patients with differentiated thyroid cancer. : The oncologist.

Chicago

Dadu Ramona, Waguespack Steven G, Sherman Steven I, Hu Mimi I, Busaidy Naifa L, Jimenez Camilo, Habra Mohammed A, Ying Anita K, Bassett Roland L and Cabanillas Maria E. 20150112. Efficacy and tolerability of different starting doses of sorafenib in patients with differentiated thyroid cancer. : The oncologist.

Harvard

Dadu R., Waguespack S. G., Sherman S. I., Hu M. I., Busaidy N. L., Jimenez C., Habra M. A., Ying A. K., Bassett R. L. and Cabanillas M. E. (20150112). Efficacy and tolerability of different starting doses of sorafenib in patients with differentiated thyroid cancer. : The oncologist.

MLA

Dadu Ramona, Waguespack Steven G, Sherman Steven I, Hu Mimi I, Busaidy Naifa L, Jimenez Camilo, Habra Mohammed A, Ying Anita K, Bassett Roland L and Cabanillas Maria E. Efficacy and tolerability of different starting doses of sorafenib in patients with differentiated thyroid cancer. : The oncologist. 20150112.